DexCom Inc. Stock Underperforms Monday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.DexCom Inc. (DXCM) shares fell 1.25% to $75.69 on Monday, underperforming competitors Abbott Laboratories and Insulet Corp. amid a broader market decline. This marks the second consecutive day of losses for DexCom, which is now trading 15.88% below its 52-week high. Trading volume remained below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of DexCom Inc. (DXCM) slipped 1.25% to $75.69 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.19% to 7,443.28 and Dow Jones Industrial Average falling 0.59% to 51,839.26.
This was the stock's second consecutive day of losses.
DexCom Inc. closed 15.88% below its 52-week high of $89.98, which the company achieved on July 30th.
The stock underperformed when compared to some of its competitors Monday, as Abbott Laboratories (ABT) rose 0.97% to $101.66 and Insulet Corp. (PODD) rose 2.02% to $167.37.
Trading volume (3.1 M) remained 2.7 million below its 50-day average volume of 5.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 20, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-20-26 1658ET